Publication | Open Access
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
139
Citations
30
References
2008
Year
Targeting CD22 depletes and reprograms B-cells and reverses autoimmune diabetes, thereby providing a blueprint for development of novel therapies to cure autoimmune diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1